339 related articles for article (PubMed ID: 25275906)
1. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Zenkel M; Schlötzer-Schrehardt U
J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
[TBL] [Abstract][Full Text] [Related]
2. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
Zenkel M
J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
[TBL] [Abstract][Full Text] [Related]
5. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
[TBL] [Abstract][Full Text] [Related]
6. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
Schlötzer-Schrehardt U; Zenkel M
Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
Wiggs JL; Pasquale LR
J Glaucoma; 2014; 23(8 Suppl 1):S62-3. PubMed ID: 25275910
[TBL] [Abstract][Full Text] [Related]
8. The management of exfoliative glaucoma.
Ritch R
Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
[TBL] [Abstract][Full Text] [Related]
9. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
10. Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population.
Chiras D; Tzika K; Kokotas H; Oliveira SC; Grigoriadou M; Kastania A; Dima K; Stefaniotou M; Aspiotis M; Petersen MB; Kroupis C; Kitsos G
Mol Vis; 2013; 19():1006-16. PubMed ID: 23687437
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.
Berner D; Zenkel M; Pasutto F; Hoja U; Liravi P; Gusek-Schneider GC; Kruse FE; Schödel J; Reis A; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5930-5940. PubMed ID: 29164236
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
[TBL] [Abstract][Full Text] [Related]
13. Compositional Analysis of Extracellular Aggregates in the Eyes of Patients With Exfoliation Syndrome and Exfoliation Glaucoma.
De Maria A; Zientek KD; David LL; Wilmarth PA; Bhorade AM; Harocopos GJ; Huang AJW; Hong AR; Siegfried CJ; Tsai LM; Sheybani A; Bassnett S
Invest Ophthalmol Vis Sci; 2021 Dec; 62(15):27. PubMed ID: 34964803
[TBL] [Abstract][Full Text] [Related]
14. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
[TBL] [Abstract][Full Text] [Related]
15. LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma.
Khan TT; Li G; Navarro ID; Kastury RD; Zeil CJ; Semchyshyn TM; Moya FJ; Epstein DL; Gonzalez P; Challa P
Mol Vis; 2010 Nov; 16():2236-41. PubMed ID: 21139690
[TBL] [Abstract][Full Text] [Related]
16. Transgenic lysyl oxidase homolog 1 overexpression in the mouse eye results in the formation and release of protein aggregates.
Zadravec P; Braunger BM; Melzer B; Kroeber M; Bösl MR; Jägle H; Schlötzer-Schrehardt U; Tamm ER
Exp Eye Res; 2019 Feb; 179():115-124. PubMed ID: 30399364
[TBL] [Abstract][Full Text] [Related]
17. Exfoliation syndrome: a disease with an environmental component.
Dewundara S; Pasquale LR
Curr Opin Ophthalmol; 2015 Mar; 26(2):78-81. PubMed ID: 25594763
[TBL] [Abstract][Full Text] [Related]
18. Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma.
Rao KN; Ritch R; Dorairaj SK; Kaur I; Liebmann JM; Thomas R; Chakrabarti S
Mol Vis; 2008 Jul; 14():1254-62. PubMed ID: 18618003
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese.
Fuse N; Miyazawa A; Nakazawa T; Mengkegale M; Otomo T; Nishida K
Mol Vis; 2008 Jul; 14():1338-43. PubMed ID: 18648524
[TBL] [Abstract][Full Text] [Related]
20. Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.
Bernstein AM; Ritch R; Wolosin JM
J Glaucoma; 2018 Jul; 27 Suppl 1(Suppl 1):S44-S53. PubMed ID: 29547474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
